A Pilot Study of Abatacept for the Treatment of Patients with Diffuse Cutaneous Systemic Sclerosis.

被引：0
|
作者：
Chakravarty, Eliza F. [1 ]
Fiorentino, David
Bennett, Mihoko
Chung, Lorinda [2 ]
机构：
[1] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[2] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
707
引用
收藏
页码：S274 / S275
页数：2
相关论文
共 50 条
  • [21] Systemic sclerosis. Objectives for the treatment
    Maurer, B.
    Walder, M.
    Gay, R. E.
    Gay, S.
    Distler, O.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (01): : 37 - +
  • [22] Development of a Composite Index for Clinical Trials in Early Diffuse Cutaneous Systemic sclerosis-the Combined Response Index in Systemic Sclerosis.
    Khanna, Dinesh
    Berrocal, Veronica
    Giannini, Edward
    Mayes, Maureen
    Merkel, Peter A.
    Siegel, Jeffrey
    Seibold, James R.
    Baron, Murray
    Clements, Philip J.
    Allanore, Yannick
    Steen, Virginia D.
    Denton, Christopher P.
    Distler, Oliver
    Johnson, Sindhu R.
    Matucci-Cerinic, Marco
    Czirjak, Lazlo
    Pope, Janet E.
    Proudman, Susanna
    Wong, Weng Kee
    Wells, Athol U.
    Furst, Daniel E.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1311 - S1312
  • [23] Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis
    Melsens, Karin
    Vandecasteele, Els
    Deschepper, Ellen
    Badot, Valerie
    Blockmans, Daniel
    Brusselle, Guy
    De Langhe, Ellen
    De Pauw, Michel
    Debusschere, Claire
    Decuman, Saskia
    Deroo, Liselotte
    Houssiau, Frederic
    Lenaerts, Jan
    Piette, Yves
    Thevissen, Kristof
    Vanthuyne, Marie
    Westhovens, Rene
    Wijnant, Sara
    De Keyser, Filip
    Smith, Vanessa
    ACTA CLINICA BELGICA, 2018, 73 (02) : 119 - 125
  • [24] Natural history of skin sclerosis associates with morbidity and mortality in early-stage diffuse cutaneous systemic sclerosis.
    Shand, L
    Hosseini, M
    Black, CM
    Denton, CP
    ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3638 - 3638
  • [25] A pilot trial of treprostinil (Remodulin®) for the treatment and prevention of digital ischemic lesions in patients with systemic sclerosis.
    Chung, L
    Fiorentino, D
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4086 - 4086
  • [26] RITUXIMAB TREATMENT IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A CASE REPORT
    Santiago, M. G.
    Santiago, T.
    Rodrigues, M.
    Costa, C.
    Carvalho, P.
    Ferreira, J.
    Serra, S.
    Salvador, M. J.
    Da Silva, J. A. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S141 - S141
  • [27] COMPARISON OF HAND FUNCTIONS AND FUNCTIONAL STATUS IN PATIENTS WITH LIMITED CUTANEOUS SYSTEMIC SCLEROSIS AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
    Akatay, E. A.
    Bayraktar, D.
    Akad, E. Otman
    Ustun, O.
    Aysin, I. Kurut
    Sarac, D. C.
    Atalay, B.
    Ramazanoglu, I.
    Tekin, I.
    Kurum, T.
    Gucenmez, S.
    Ozmen, M.
    Akar, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1111 - 1112
  • [28] Association of anti-fibrillarin autoantibodies with poor outcome in diffuse but not limited cutaneous systemic sclerosis.
    Denton, CJ
    Tormey, VJ
    Bunn, CC
    Black, CM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S130 - S130
  • [29] Ziritaxestat in diffuse cutaneous systemic sclerosis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2023, 5 (04): : E182 - E182
  • [30] Lenabasum for diffuse cutaneous systemic sclerosis
    Brooks, Helen
    Clark, Anna
    Van Epps, Heather
    LANCET RHEUMATOLOGY, 2021, 3 (08): : E551 - E552
12345